BX Swiss TOP 30 CHF

BX Swiss TOP 30 CHF handeln
1.380,87 PKT +13,44 PKT +0,98 %
finanzen.net zero
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

WKN SL0CLV

ISIN DE000SL0CLV3


Analysen zu BX Swiss TOP 30 CHF-Werten

Datum Rating Analyst
01.02.17 Givaudan buy Baader Bank
01.02.17 UBS Hold Deutsche Bank AG
01.02.17 Swiss Re Sell UBS AG
01.02.17 Givaudan Hold Deutsche Bank AG
01.02.17 Givaudan overweight JP Morgan Chase & Co.
01.02.17 Givaudan Sell Citigroup Corp.
01.02.17 Holcim overweight Morgan Stanley
01.02.17 Holcim kaufen HSBC
31.01.17 Nestlé overweight JP Morgan Chase & Co.
31.01.17 UBS Underperform BNP PARIBAS
31.01.17 Novartis Hold Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
30.01.17 UBS overweight Barclays Capital
30.01.17 UBS overweight Morgan Stanley
30.01.17 UBS Neutral JP Morgan Chase & Co.
30.01.17 Novartis Neutral JP Morgan Chase & Co.
30.01.17 Novartis Neutral UBS AG
30.01.17 Novartis buy HSBC
30.01.17 UBS Neutral Goldman Sachs Group Inc.
27.01.17 UBS Outperform BMO Capital Markets
27.01.17 UBS buy Citigroup Corp.
27.01.17 UBS buy Citigroup Corp.
27.01.17 UBS Neutral Credit Suisse Group
27.01.17 UBS Outperform RBC Capital Markets
27.01.17 Swiss Re buy Goldman Sachs Group Inc.
27.01.17 UBS overweight Barclays Capital
27.01.17 UBS buy S&P Capital IQ
27.01.17 UBS buy Baader Bank
27.01.17 UBS Hold Commerzbank AG
26.01.17 ABB (Asea Brown Boveri) overweight Morgan Stanley
26.01.17 Novartis Underweight Morgan Stanley
26.01.17 Novartis Hold Deutsche Bank AG
26.01.17 UBS Neutral Goldman Sachs Group Inc.
26.01.17 UBS buy Goldman Sachs Group Inc.
25.01.17 UBS Buy UBS AG
25.01.17 Novartis Hold S&P Capital IQ
25.01.17 UBS Hold Deutsche Bank AG
25.01.17 UBS Hold Deutsche Bank AG
25.01.17 Nestlé buy UBS AG
25.01.17 Nestlé overweight JP Morgan Chase & Co.
25.01.17 Nestlé overweight JP Morgan Chase & Co.